Well, after having my head handed to me by V.SSS a few years ago ...I swore I would never ride another FDA / phase result on a junior biotech...I will only buy and hold but always sell before the results are finally released.
In the one in a million chance it is a blockbuster ...I am willing to buy back in at a higher price.
Next on the radar....SDI...also in a phase III and will surely enjoy a ride up over the next months / year.
Good luck to whom ever looks at this stock...
As for NPC it is likely over....a reverse split is likely the only option to raise capital in the future. 1 for 10 or something like that...followed by the usual financings and the years (5-10) to see another set of trials from start to finish.
That junior biotechs for you.